title: Cannabinoids and B cells: emerging targets for treating progressive multiple sclerosis.
authors.forename: Gavin
authors.initials: G
authors.lastname: Giovannoni
mesh_terms: D000818:Animals; D001402:B-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D054382:Chemokine CXCL13 / Q000134:cerebrospinal fluid; D004185:Disability Evaluation; D006801:Humans; D007075:Immunoglobulin M / Q000096:biosynthesis; D007155:Immunologic Factors / Q000627:therapeutic use*; D020528:Multiple Sclerosis, Chronic Progressive / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D043025:Oligoclonal Bands / Q000134:cerebrospinal fluid; D011110:Polymorphism, Genetic; D011379:Prognosis; D043884:Receptor, Cannabinoid, CB1 / Q000819:agonists* / Q000235:genetics; D012720:Severity of Illness Index
chemical_list: C110663:CXCL13 protein, human; D054382:Chemokine CXCL13; D007075:Immunoglobulin M; D007155:Immunologic Factors; D043025:Oligoclonal Bands; D043884:Receptor, Cannabinoid, CB1